Jill Tanner
Physician Assistant · Los Angeles, CANPI 1528434313
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 205 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 11.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,418 and has fallen 81.4% since, to $449 in 2025. Among physician assistant clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 205 payments — averaging $23.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$529
- Novartis$502
- Esperion Therapeutics, Inc.$443
- Abbott$418
- Boston Scientific$406
- Amgen$382
- plus $2K from 21 others
What the payments were for
- Food & beverage$4,777100%
- Education$200%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 5 | $529 |
| Novartis | 32 | $502 |
| Esperion Therapeutics, Inc. | 18 | $443 |
| Abbott | 23 | $418 |
| Boston Scientific | 7 | $406 |
| Amgen | 24 | $382 |
| Novo Nordisk | 16 | $340 |
| E.r. Squibb & Sons, L.L.C. | 11 | $268 |
| Pfizer | 9 | $212 |
| Johnson & Johnson | 10 | $211 |
| AbbVie | 8 | $184 |
| AstraZeneca | 7 | $141 |
| Boehringer Ingelheim | 5 | $123 |
| Amarin Pharma, Inc. | 4 | $94 |
| Bayer | 3 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $66 |
| Lilly USA, LLC | 3 | $66 |
| Merck | 3 | $55 |
| Regeneron Healthcare Solutions, Inc. | 2 | $49 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $48 |
| Actelion Pharmaceuticals US, Inc. | 2 | $34 |
| Kowa Pharmaceuticals America, Inc. | 2 | $33 |
| Heartflow, Inc. | 1 | $31 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $29 |
| Dexcom, Inc. | 1 | $29 |
| Cardiva Medical, Inc. | 1 | $26 |
| Currax Pharmaceuticals LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,797 in reported general payments places this provider in the 90th percentile of 10,423 physician assistant providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 113 | $91,329 |
| Repatha SureclickEvolocumab | 64 | $68,259 |
| JardianceEmpagliflozin | 35 | $38,930 |
| OzempicSemaglutide | 22 | $25,284 |
| XareltoRivaroxaban | 16 | $23,196 |
| MounjaroTirzepatide | 16 | $20,010 |
| FarxigaDapagliflozin Propanediol | 19 | $17,814 |
| BrilintaTicagrelor | 12 | $11,231 |
| PaxlovidNirmatrelvir/Ritonavir | 37 | $5,594 |
| Telmisartan | 93 | $2,887 |
| Rosuvastatin Calcium | 129 | $2,130 |
| Atorvastatin Calcium | 185 | $2,073 |
| Metoprolol Succinate | 154 | $2,034 |
| Ezetimibe | 50 | $1,295 |
| Famotidine | 71 | $1,249 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Paxlovid | $212 | $96,923150 claims |
| Boehringer IngelheimJardiance | $123 | $38,93035 claims |
| AstraZenecaFarxiga, Brilinta | $141 | $29,04531 claims |
| Novo NordiskOzempic | $340 | $25,28422 claims |
| Johnson & JohnsonXarelto | $211 | $23,19616 claims |
| Lilly USA, LLCMounjaro | $66 | $20,01016 claims |
| AbbVieSynthroid | $184 | $84417 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,423 physician assistant providers in California.
Other physician assistant in Los Angeles
- Asia SullivanLos Angeles$61K
- Felipe FindleyLos Angeles$51K
- Melissa GriffinLos Angeles$39K
- Andrea NguyenIrvine$1M
- Mikhail AlperMadera$889K
- Erin JensenUpland$716K
- Franklin ClineSacramento$458K
- Carla CrespoMarina del Rey$297K
- Katherine OsakiEl Centro$274K
- Shawna JonesFountain Valley$266K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.